Australia mulls chemical supply chain actions to stop terrorism
Australia is considering steps to stop chemicals used in drug manufacturing from being diverted by terrorists to make explosives.
Australia is considering steps to stop chemicals used in drug manufacturing from being diverted by terrorists to make explosives.
Covance is investing to win business from “distracted competitors” that have been part of mergers and buyouts, an analyst claims.
A proposed US act aims to impose limitations on consent decrees and stop the “regulatory frenzy in Washington”.
Logistics contractor Marken plans to ramp up its activities in China with a new Beijing depot set to open later this year.
Foreign currency effects left Indian contractor Jubilant Life Sciences with a third quarter loss despite record sales.
Shanghai Pharmaceuticals has bought a 70 per cent stake in ingredients developer and manufacturer Changzhou Kony Pharm in a bid to boost its standing in the API market.